Search by Drug Name or NDC

    NDC 27854-0115-01 Melox 200; 20; 200 mg/5mL; mg/5mL; mg/5mL Details

    Melox 200; 20; 200 mg/5mL; mg/5mL; mg/5mL

    Melox is a ORAL SUSPENSION in the HUMAN OTC DRUG category. It is labeled and distributed by Belmora LLC. The primary component is ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE.

    Product Information

    NDC 27854-0115
    Product ID 27854-115_cb37d74c-450d-462e-bf2c-8bec9864a35f
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Melox
    Proprietary Name Suffix n/a
    Non-Proprietary Name Aluminum hydroxide, Magnesium hydroxide, Simethicone
    Product Type HUMAN OTC DRUG
    Dosage Form SUSPENSION
    Route ORAL
    Active Ingredient Strength 200; 20; 200
    Active Ingredient Units mg/5mL; mg/5mL; mg/5mL
    Substance Name ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE
    Labeler Name Belmora LLC
    Pharmaceutical Class Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part331
    Listing Certified Through 2024-12-31

    Package

    NDC 27854-0115-01 (27854011501)

    NDC Package Code 27854-115-01
    Billing NDC 27854011501
    Package 355 mL in 1 BOTTLE (27854-115-01)
    Marketing Start Date 2018-06-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL d41f0b26-5add-4045-9754-37d70d120d28 Details

    Revised: 11/2020